Table of Contents
ISRN Pulmonology
Volume 2012 (2012), Article ID 153971, 11 pages
http://dx.doi.org/10.5402/2012/153971
Research Article

An Assessment of Epithelial and Mesenchymal Phenotypes in Experimental and Clinical Pulmonary Fibrosis

1Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd., Granta Park, Cambridge CB21 6GH, UK
2Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
3Department of Internal Medicine, Yale University School of Medicine, 300 Cedar Street, TAC 441S, New Haven, CT 06520, USA
4James Hogg iCAPTURE Centre, Institute for Heart and Lung Health, Vancouver, BC, Canada V6Z 1Y6
5Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada V6Z 1Y6
6Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI 48109, USA

Received 11 June 2012; Accepted 12 July 2012

Academic Editors: J. Ho and A. Miyazato

Copyright © 2012 Rebecca Dunmore et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Tzilas, A. Koti, D. Papandrinopoulou, and G. Tsoukalas, “Prognostic factors in idiopathic pulmonary fibrosis,” American Journal of the Medical Sciences, vol. 338, no. 6, pp. 481–485, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Navaratnam, K. M. Fleming, J. West et al., “The rising incidence of idiopathic pulmonary fibrosis in the UK,” Thorax, vol. 66, no. 6, pp. 462–467, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. K. Frankel and M. I. Schwarz, “Update in idiopathic pulmonary fibrosis,” Current Opinion in Pulmonary Medicine, vol. 15, no. 5, pp. 463–469, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. T. J. Gross and G. W. Hunninghake, “Idiopathic pulmonary fibrosis,” The New England Journal of Medicine, vol. 345, no. 7, pp. 517–525, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. P. W. Noble and R. J. Homer, “Idiopathic pulmonary fibrosis: new insights into pathogenesis,” Clinics in Chest Medicine, vol. 25, no. 4, pp. 749–758, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Raghu and J. Chang, “Idiopathic pulmonary fibrosis: current trends in management,” Clinics in Chest Medicine, vol. 25, no. 4, pp. 621–636, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Selman, T. E. King, and A. Pardo, “Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy,” Annals of Internal Medicine, vol. 134, no. 2, pp. 136–151, 2001. View at Google Scholar · View at Scopus
  8. K. Kuwano, “Involvement of epithelial cell apoptosis in interstitial lung diseases,” Internal Medicine, vol. 47, no. 5, pp. 345–353, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. R. J. Homer, J. A. Elias, C. G. Lee, and E. Herzog, “Modern concepts on the role of inflammation in pulmonary fibrosis,” Archives of Pathology and Laboratory Medicine, vol. 135, no. 6, pp. 780–788, 2011. View at Google Scholar · View at Scopus
  10. B. C. Willis, J. M. Liebler, K. Luby-Phelps et al., “Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-β1: potential role in idiopathic pulmonary fibrosis,” American Journal of Pathology, vol. 166, no. 5, pp. 1321–1332, 2005. View at Google Scholar · View at Scopus
  11. K. K. Kim, M. C. Kugler, P. J. Wolters et al., “Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix,” The Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 35, pp. 13180–13185, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. B. C. Willis and Z. Borok, “TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 293, no. 3, pp. L525–L534, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. N. J. Lomas, K. L. Watts, K. M. Akram, N. R. Forsyth, and M. A. Spiteri, “Idiopathic pulmonary fibrosis: immunohistochemical analysis provides fresh insights into lung tissue remodelling with implications for novel prognostic markers,” International Journal of Clinical and Experimental Pathology, vol. 5, no. 1, pp. 58–71, 2012. View at Google Scholar
  14. S. Grünert, M. Jechlinger, and H. Beug, “Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis,” Nature Reviews Molecular Cell Biology, vol. 4, no. 8, pp. 657–665, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Iwano, D. Plieth, T. M. Danoff, C. Xue, H. Okada, and E. G. Neilson, “Evidence that fibroblasts derive from epithelium during tissue fibrosis,” Journal of Clinical Investigation, vol. 110, no. 3, pp. 341–350, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Khalil, R. N. O'Connor, H. W. Unruh et al., “Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 5, no. 2, pp. 155–162, 1991. View at Google Scholar · View at Scopus
  17. N. Khalil, T. V. Parekh, R. O'Connor et al., “Regulation of the effects of TGF-β1 by activation of latent TGF-β1 and differential expression of TGF-β receptors (TβR-I and TβR-II) in idiopathic pulmonary fibrosis,” Thorax, vol. 56, no. 12, pp. 907–915, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. C. G. Lee, S. J. Cho, M. J. Kang et al., “Early growth response gene 1-mediated apoptosis is essential for transforming growth factor β1-induced pulmonary fibrosis,” Journal of Experimental Medicine, vol. 200, no. 3, pp. 377–389, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. C. M. Swaisgood, E. L. French, C. Noga, R. H. Simon, and V. A. Ploplis, “The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system,” American Journal of Pathology, vol. 157, no. 1, pp. 177–187, 2000. View at Google Scholar · View at Scopus
  20. M. D. Burdick, L. A. Murray, M. P. Keane et al., “CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 3, pp. 261–268, 2005. View at Google Scholar
  21. K. R. Flaherty, T. E. King, G. Raghu et al., “Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?” American Journal of Respiratory and Critical Care Medicine, vol. 170, no. 8, pp. 904–910, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Yamauchi, T. Kohyama, H. Takizawa et al., “Tumor necrosis factor-α enhances both epithelial-mesenchymal transition and cell contraction induced in A549 human alveolar epithelial cells by transforming growth factor-β1,” Experimental Lung Research, vol. 36, no. 1, pp. 12–24, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Kasai, J. T. Allen, R. M. Mason, T. Kamimura, and Z. Zhang, “TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT),” Respiratory Research, vol. 6, article 56, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. L. A. Borthwick, A. Gardner, A. de Soyza, D. A. Mann, and A. J. Fisher, “Transforming growth factor-β1 (TGF-β1) driven epithelial to mesenchymal transition (EMT) is accentuated by tumour necrosis factor α (TNFα) via crosstalk between the SMAD and NF-κB pathways,” Cancer Microenvironment, vol. 5, no. 1, pp. 45–57, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. P. M. Siegel and J. Massagué, “Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer,” Nature Reviews Cancer, vol. 3, no. 11, pp. 807–821, 2003. View at Google Scholar · View at Scopus
  26. S. R. Oak, L. Murray, A. Herath et al., “A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis,” PLoS ONE, vol. 6, no. 6, Article ID e21253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. E. D. Hay, “The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it,” Developmental Dynamics, vol. 233, no. 3, pp. 706–720, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Kalluri and E. G. Neilson, “Epithelial-mesenchymal transition and its implications for fibrosis,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1776–1784, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Kalluri and R. A. Weinberg, “The basics of epithelial-mesenchymal transition,” Journal of Clinical Investigation, vol. 119, no. 6, pp. 1420–1428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. U. Valcourt, M. Kowanetz, H. Niimi, C. H. Heldin, and A. Moustakas, “TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition,” Molecular Biology of the Cell, vol. 16, no. 4, pp. 1987–2002, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Königshoff, M. Kramer, N. Balsara et al., “WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis,” Journal of Clinical Investigation, vol. 119, no. 4, pp. 772–787, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. J. R. Rock, C. E. Barkauskas, M. J. Cronce et al., “Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition,” The Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 52, pp. E1475–E1483, 2012. View at Publisher · View at Google Scholar
  33. T. L. Hackett, S. M. Warner, D. Stefanowicz et al., “Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-β1,” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 2, pp. 122–133, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Marmai, R. E. Sutherland, K. K. Kim et al., “Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 301, no. 1, pp. L71–L78, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Jenkins, A. Blanchard, Z. Borok et al., “In search of the fibrotic epithelial cell: opportunities for a collaborative network,” Thorax, vol. 67, no. 2, pp. 179–182, 2012. View at Publisher · View at Google Scholar
  36. A. M. Doerner and B. L. Zuraw, “TGF-β1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1β but not abrogated by corticosteroids,” Respiratory Research, vol. 10, article 100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Câmara and G. Jarai, “Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-α,” Fibrogenesis and Tissue Repair, vol. 3, no. 1, article 2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. H. R. Kang, G. L. Chun, R. J. Homer, and J. A. Elias, “Semaphorin 7A plays a critical role in TGF-β1-induced pulmonary fibrosis,” Journal of Experimental Medicine, vol. 204, no. 5, pp. 1083–1093, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. V. V. Polosukhin, A. L. Degryse, D. C. Newcomb et al., “Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice,” Experimental Lung Research, vol. 38, no. 3, pp. 135–146, 2012. View at Publisher · View at Google Scholar
  40. N. Schuster and K. Krieglstein, “Mechanisms of TGF-β-mediated apoptosis,” Cell and Tissue Research, vol. 307, no. 1, pp. 1–14, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. I. Le Jeune, J. Gribbin, J. West, C. Smith, P. Cullinan, and R. Hubbard, “The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK,” Respiratory Medicine, vol. 101, no. 12, pp. 2534–2540, 2007. View at Publisher · View at Google Scholar · View at Scopus